AMBRA1 is a predictive biomarker of melanoma response to targeted therapy by L. Di Leo, C. Pagliuca, A. Kishk, S. Rizza, C. Tsiavou, C. Pecorari, C. Dahl, M. Pacheco, R. Tholstrup, J. Brewer, P. Berico, E. Hernando, F. Cecconi, R. Ballotti, C. Bertolotto, G. Filomeni, M. Gjerstorff, T. Sauter, P. Lovat, P. Guldberg, D. De Zio

Get full text